Sana Biotechnology Stock Market Value
| SANA Stock | USD 4.86 0.03 0.62% |
| Symbol | Sana |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sana Biotechnology. If investors know Sana will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sana Biotechnology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Sana Biotechnology is measured differently than its book value, which is the value of Sana that is recorded on the company's balance sheet. Investors also form their own opinion of Sana Biotechnology's value that differs from its market value or its book value, called intrinsic value, which is Sana Biotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sana Biotechnology's market value can be influenced by many factors that don't directly affect Sana Biotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sana Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sana Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sana Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Sana Biotechnology 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Sana Biotechnology's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Sana Biotechnology.
| 10/28/2025 |
| 01/26/2026 |
If you would invest 0.00 in Sana Biotechnology on October 28, 2025 and sell it all today you would earn a total of 0.00 from holding Sana Biotechnology or generate 0.0% return on investment in Sana Biotechnology over 90 days. Sana Biotechnology is related to or competes with Nurix Therapeutics, Inhibrx Biosciences, Nektar Therapeutics, Syndax Pharmaceuticals, Dianthus Therapeutics, Kodiak Sciences, and Phathom Pharmaceuticals. Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines More
Sana Biotechnology Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Sana Biotechnology's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Sana Biotechnology upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.02) | |||
| Maximum Drawdown | 25.63 | |||
| Value At Risk | (8.77) | |||
| Potential Upside | 12.59 |
Sana Biotechnology Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Sana Biotechnology's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Sana Biotechnology's standard deviation. In reality, there are many statistical measures that can use Sana Biotechnology historical prices to predict the future Sana Biotechnology's volatility.| Risk Adjusted Performance | 0.0019 | |||
| Jensen Alpha | (0.27) | |||
| Total Risk Alpha | (0.60) | |||
| Treynor Ratio | (0.02) |
Sana Biotechnology January 26, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0019 | |||
| Market Risk Adjusted Performance | (0.01) | |||
| Mean Deviation | 4.29 | |||
| Coefficient Of Variation | (10,786) | |||
| Standard Deviation | 5.76 | |||
| Variance | 33.15 | |||
| Information Ratio | (0.02) | |||
| Jensen Alpha | (0.27) | |||
| Total Risk Alpha | (0.60) | |||
| Treynor Ratio | (0.02) | |||
| Maximum Drawdown | 25.63 | |||
| Value At Risk | (8.77) | |||
| Potential Upside | 12.59 | |||
| Skewness | 0.7235 | |||
| Kurtosis | 0.6156 |
Sana Biotechnology Backtested Returns
Sana Biotechnology owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0128, which indicates the firm had a -0.0128 % return per unit of risk over the last 3 months. Sana Biotechnology exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Sana Biotechnology's Risk Adjusted Performance of 0.0019, coefficient of variation of (10,786), and Variance of 33.15 to confirm the risk estimate we provide. The entity has a beta of 3.08, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Sana Biotechnology will likely underperform. At this point, Sana Biotechnology has a negative expected return of -0.075%. Please make sure to validate Sana Biotechnology's accumulation distribution, and the relationship between the potential upside and day median price , to decide if Sana Biotechnology performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.63 |
Good predictability
Sana Biotechnology has good predictability. Overlapping area represents the amount of predictability between Sana Biotechnology time series from 28th of October 2025 to 12th of December 2025 and 12th of December 2025 to 26th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Sana Biotechnology price movement. The serial correlation of 0.63 indicates that roughly 63.0% of current Sana Biotechnology price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.63 | |
| Spearman Rank Test | 0.01 | |
| Residual Average | 0.0 | |
| Price Variance | 0.09 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Sana Biotechnology offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sana Biotechnology's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sana Biotechnology Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sana Biotechnology Stock:Check out Sana Biotechnology Correlation, Sana Biotechnology Volatility and Sana Biotechnology Alpha and Beta module to complement your research on Sana Biotechnology. For information on how to trade Sana Stock refer to our How to Trade Sana Stock guide.You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Sana Biotechnology technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.